ESLA

2.93

6.16% 0.17

Handel nachbörslich: 2.88 -0.05 -1.71%

Estrella Immunopharma Inc (ESLA)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$2.76

Offen:

$2.73

24-Stunden-Volumen:

469.80K

Relative Volume:

2.28

Marktkapitalisierung:

$108.60M

Einnahmen:

Nettoeinkommen (Verlust:

$-8.82M

KGV:

-9.7667

EPS:

-0.3

Netto-Cashflow:

$-18.01M

1W Leistung:

+21.07%

1M Leistung:

+132.60%

6M Leistung:

+161.61%

1J Leistung:

+265.79%

1-Tages-Spanne:

$2.62

$3.01

1-Wochen-Bereich:

$2.155

$3.15

52-Wochen-Spanne:

$0.7001

$3.15

Estrella Immunopharma Inc Stock (ESLA) Company Profile

Firmenname

Estrella Immunopharma Inc

Sektor

Healthcare (1134)

Branche

Biotechnology (636)

Telefon

(510) 318-9098

Adresse

5858 HORTON STREET, SUITE 370, EMERYVILLE

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

ESLA's Discussions on Twitter

Vergleichen Sie ESLA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ESLA Estrella Immunopharma Inc	2.93	102.30M	0	-8.82M	-18.01M	-0.30
VRTX Vertex Pharmaceuticals Inc	409.47	105.61B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	657.53	67.99B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	442.70	58.19B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	854.65	52.40B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.70	39.60B	447.02M	-1.18B	-906.14M	-6.1812

Estrella Immunopharma Inc Aktie (ESLA) Neueste Nachrichten

10:41 AM

How to integrate Estrella Immunopharma Inc. into portfolio analysis toolsPortfolio Gains Summary & High Accuracy Trade Signal Alerts - newser.com

10:41 AM

05:56 AM

What data driven models say about Estrella Immunopharma Inc.’s futurePortfolio Risk Report & Free Fast Gain Swing Trade Alerts - newser.com

05:56 AM

Nov 06, 2025

Estrella Immunopharma Achieves Milestone in STARLIGHT-1 Trial - TipRanks

Nov 06, 2025

[8-K] Estrella Immunopharma, Inc. Reports Material Event | ESLA SEC FilingForm 8-K - Stock Titan

Nov 06, 2025

Is Estrella Immunopharma Inc. stock oversold or undervaluedQuarterly Market Summary & AI Enhanced Execution Alerts - newser.com

Nov 06, 2025

Nov 05, 2025

Is Estrella Immunopharma Inc. reversing from oversold territoryJuly 2025 Macro Moves & Advanced Technical Signal Analysis - newser.com

Nov 05, 2025

Is Estrella Immunopharma Inc. building a consolidation basePortfolio Value Report & AI Powered Buy/Sell Recommendations - newser.com

Nov 05, 2025

Is Estrella Immunopharma Inc. stock ready for breakoutJuly 2025 Institutional & Consistent Profit Alerts - newser.com

Nov 05, 2025

Nov 04, 2025

Top 100 Stocks to Buy: Two Penny Stocks Moved Up 51 Spots. Should You Buy Either? - Barchart.com

Nov 04, 2025

Estrella Immunopharma's (ESLA) "Buy" Rating Reaffirmed at D. Boral Capital - MarketBeat

Nov 04, 2025

Check out these key findings about Estrella Immunopharma Inc (ESLA) - setenews.com

Nov 04, 2025

Using data models to predict Estrella Immunopharma Inc. stock movementQuarterly Trade Report & Reliable Momentum Entry Alerts - newser.com

Nov 04, 2025

Estrella Immunopharma (NASDAQ:ESLA) Given “Buy” Rating at D. Boral Capital - Defense World

Nov 04, 2025

Analyst Jason Kolbert Maintains Buy Rating on ESLA | ESLA Stock News - GuruFocus

Nov 04, 2025

Nov 03, 2025

Estrella Immunopharma Completes Second Dose Cohort in STARLIGHT-1 Trial of EB103 with Complete Responses in All Evaluable Patients - BioSpace

Nov 03, 2025

Estrella Immunopharma stock soars after 100% complete response rate in trial - Investing.com Australia

Nov 03, 2025

Is now a turning point for Estrella Immunopharma Inc.Quarterly Portfolio Summary & Growth-Oriented Investment Plans - newser.com

Nov 03, 2025